MarketPeel
Insider Trading Intelligence
Pricing
…
MJ

Mitchell Lawrence Jones

PALI
CHIEF MEDICAL OFFICER · PALISADE BIO, INC. · CIK 0001993292
FILING MIX · LIFETIME48%/52%
BUYS
16
SELLS
17
TOTAL VALUE
$119.0K
COMPANIES
1
ACTIVE SINCE
Nov 2023
HOLDINGS NOW
94,009
AVG SELL PX
$2.02
TRADE KIND
SHOWING 33 / 33
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mitchell Lawrence Jones, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-6.32%+0.47%-6.79%-6.79%—
14d1+0.00%+6.32%+1.18%+5.14%+5.14%—
30d1+0.00%+11.49%-2.79%+14.28%+14.28%—
60d1+0.00%+14.37%+0.71%+13.66%+13.66%—
90d1+0.00%+7.47%+8.96%-1.49%-1.49%—
180d1(1 pending)——————
1y1(1 pending)——————
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PALI · 94,009 shares · as of Jul 7, 2026
01,916,4503,832,9005,749,3507,665,800202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 16 buys / 17 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
51,880$2.05$106.5K94,009Jul 7, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
131,167——145,889Jul 6, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
131,167——655,833Jul 6, 2026Jul 8, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
1,989$1.75$3.5K13,263Feb 12, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
8,000——15,252Feb 11, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
8,000——16,000Feb 11, 2026Feb 13, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
787,000——787,000Feb 9, 2026Feb 11, 2026 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
7,665,800——7,665,800Oct 6, 2025Oct 8, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
289,000——289,000Sep 4, 2025Sep 5, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
29,000——29,000Feb 11, 2025Feb 13, 2025 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Feb 11, 2025Feb 13, 2025 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
2,735——0May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
461$4.76$2.2K3,852May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
1,555——4,313May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
810$4.76$3.9K2,758May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
1,555——0May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
2,735——3,568May 28, 2024May 30, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
156——1,555May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
304——2,735May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
47$8.46$398833May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
304——814May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
CEO, CFO, Director
156——880May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
CEO, CFO, Director
90$8.46$761724May 6, 2024May 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
2,333——9,815Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
4,558——45,586Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
2,333——25,667Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
2,153$0.44$9397,662Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
4,558——7,482Feb 6, 2024Feb 8, 2024 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
28,000——28,000Nov 21, 2023Nov 24, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASEGRANT
Stock grant
33,160——33,160Nov 21, 2023Nov 24, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
1,630$0.54$8782,926Nov 7, 2023Nov 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
SALE
Chief Medical Officer
4,556——50,144Nov 6, 2023Nov 8, 2023 ↗View →
PALI
PALISADE BIO, INC.
PURCHASE
Chief Medical Officer
4,556——4,556Nov 6, 2023Nov 8, 2023 ↗View →
Other insiders · PALI
Loading peer insiders…
About this filer
CIK 0001993292
ROLE
Chief Medical Officer
PRIMARY
PALI
COMPANIES
1
ACTIVE SINCE
Nov 2023
MARKETPEEL · /INSIDER/0001993292DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback